WhatsApp
backNews Article

Evonile Pharma Limited Passes Special Resolutions for Employee Stock Options and Asset Charge Creation with Over 99% Shareholder Approval

Shareholders approved granting at least 1% of issued share capital in stock options and sanctioned creation of charge on company assets as of November 12, 2026

Evonile Pharma Limited announced the successful passing of two special resolutions through postal ballot: approval of an Employee Stock Option Scheme granting at least 1% of issued capital to employees, and authorization to create a charge on company assets per Section 180(1)(a). Both resolutions achieved over 99% shareholder approval with remote e-voting completed by November 12, 2026.

6 days ago|EVONILE-1.65%
Evonile Pharma Limited500672Corporate Action

Evonile Pharma Limited

Corporate Action

Evonile Pharma Limited has obtained shareholder approval through postal ballot for two key corporate actions: granting employee stock options equalling or exceeding 1% of issued capital under its Employee Stock Option Scheme 2026, and authorizing the creation of a charge on company assets in compliance with Section 180(1)(a) of the Companies Act.

The resolutions were passed via remote electronic voting by the company’s shareholders concluding on November 12, 2026, achieving an overall voting turnout of approximately 73.23% of outstanding shares.

For the Employee Stock Option Scheme 2026, all votes cast by the promoter and promoter group were in favor, representing 100% support of their 17,450,720 shares. Public institutions and non-institutional investors also largely supported the resolution, resulting in a 99.79% overall approval rate.

Similarly, the resolution to approve creation of charge on company assets was passed with 99.79% shareholder approval. This authorization enables the company to create security interests on its assets as required for financing or other strategic purposes.

The postal ballot notices were issued on October 8, 2026, with voting eligibility as per the shareholder record date on October 9, 2026. Full voting results and the scrutinizer's report were disclosed on November 13, 2026, in accordance with SEBI Listing Regulations.

Highlights

  • Employee Stock Option Scheme 2026 approved to grant equal or more than 1% of issued capital to identified employees.
  • Creation of charge on company assets authorized under Section 180(1)(a) as a special resolution.
  • Resolutions passed with approximately 99.79% shareholder votes in favor.
  • Remote e-voting concluded on November 12, 2026, with 73.23% of shares voting.
  • Promoter and promoter group held 17,450,720 shares, voting 100% in favor.
  • Public institution and non-institutional investors showed strong majority support.

Key Data Snapshot

Date of postal ballot result declarationNovember 12, 2026
Total shareholders on record date (October 09, 2026)39691
Shareholder voting turnout on resolution (%)73.23%
Promoter and promoter group shares held17,450,720
Employee Stock Option Scheme approval votes in favor99.79%
Creation of charge on assets approval votes in favor99.79%

What happened

  • Evonile Pharma Limited completed a postal ballot approving two special resolutions by its shareholders as of November 12, 2026.
  • The approved resolutions include the Employee Stock Option Scheme 2026 and the creation of charge on company assets.

Key details

  • Employee Stock Option Scheme allows grant of stock options equal to or more than 1% of issued capital to identified employees.
  • Charge creation authorized under Section 180(1)(a) of the Companies Act, permitting security interests on company assets.
  • Resolutions passed by over 99.7% approval through remote electronic voting.

Regulatory and governance context

  • Voting conducted in accordance with Companies Act, 2013 and SEBI Listing Regulations.
  • Voting results and scrutinizer report published on company website for transparency.
  • Postal ballot notice issued on October 8, 2026; shareholder eligibility fixed as of October 9, 2026.

More News on Corporate Action

View all

Latest corporate announcements and market updates in Corporate Action.

View all news
Evonile Pharma Limited Passes Special Resolutions for | Stockk News